Explore the reasons behind patient hesitation regarding biosimilars and learn practical strategies to build trust. This guide clarifies the science, safety data, and cost implications to reduce fear and improve adoption rates.
The FDA's Purple Book is the official source for understanding which biological drugs are biosimilars and which can be swapped at the pharmacy. Learn how interchangeability works, why it matters, and how to use the database.
Europe led the world in biosimilar adoption with clear regulations and high uptake. The US lagged due to patents and strict rules-but is now accelerating fast. Here's how the two markets compare today and where they're headed.